http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2105971-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcf52764549e50e5dd0de2b178c8cd50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 1995-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54afcfbc622d8f3df00cd3a5956c0d4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0cbc0c499e5569741ac50d5f71a40c9
publicationDate 1997-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2105971-A1
titleOfInvention ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.
abstract ANTIBIOTIC/ANTI-INFLAMMATORY COMPOSITION FOR EAR APPLICATION INCLUDES: 0.1-0.4 G OF CIPROFLOXACIN, 0.2-1.5 G OF HYDROCORTISONE, 0.3-0.8 G OF 20% LACTIC ACID; 0.3-0.6 G OF 1M HYDROCHLORIC ACID, 1-3 G OF GLUCOSE, 1-3 G OF A VISCOSIZER (PREFERABLY POLYVINYLPYRROLIDONE), 30-60 G OF A COSOLVENT (PREFERABLY PROPYLENE GLYCOL OR POLYETHYLENE GLYCOL), 1-3 G OF POLYOXYETHYLENE POLYSORBATE, AND 0.01-0.08 G OF A PRESERVATIVE AGENT CHOSEN AMONG METHYL P-HYDROXYBENZOATE, ETHYL P-HYDROXYBENZOATE AND PROPYL P-HYDROXYBENZOATE. IT IS USEFUL FOR THE TOPICAL TREATMENT OF OTITIS, ESPECIALLY OTITIS MEDIA ACCOMPANIED BY A GENERAL INFLAMMATORY PROCESS. IT HAS THE ADVANTAGE THAT IT CAN BE APPLIED TO CHILDREN, AND THAT IT DOES NOT PRESENT THE RISK OF OTOTOXICITY IN CASES OF PERFORATION OF THE EARDRUM, ASSOCIATED WITH OTHER COMBINATIONS OF ANTIBIOTICS AND ANTI-INFLAMMATORIES USED TOPICALLY.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2160090-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2245611-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2171147-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006003229-A1
priorityDate 1995-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9001933-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4844902-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523006
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324

Total number of triples: 35.